
Company valuation, historical trends, and peer comparisons.
According to Resverlogix Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 96.00M. This represents a change of 16.48% compared to the average of 82.42M of the last 4 quarters.
The mean historical Enterprise Value of Resverlogix Corp. over the last ten years is 160.38M. The current 96.00M Enterprise Value has changed -40.14% with respect to the historical average. Over the past ten years (40 quarters), RVXCF's Enterprise Value was at its highest in in the April 2019 quarter at 642.91M. The Enterprise Value was at its lowest in in the September 2023 quarter at 20.66M.
Average
160.38M
Median
120.42M
Minimum
24.15M
Maximum
613.68M
Discovering the peaks and valleys of Resverlogix Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 341.66%
Maximum Annual Enterprise Value = 613.68M
Minimum Annual Increase = -77.66%
Minimum Annual Enterprise Value = 24.15M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 93.42M | 1.06% |
| 2024 | 92.44M | 282.76% |
| 2023 | 24.15M | -26.20% |
| 2022 | 32.73M | -68.46% |
| 2021 | 103.75M | -38.02% |
| 2020 | 167.40M | 22.12% |
| 2020 | 137.08M | -77.66% |
| 2019 | 613.68M | 341.66% |
| 2018 | 138.95M | -30.59% |
| 2017 | 200.19M | 46.83% |
The current Enterprise Value of Resverlogix Corp. (RVXCF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
70.01M
5-year avg
69.30M
10-year avg
160.38M
Resverlogix Corp.’s Enterprise Value is greater than Finch Therapeutics Group, Inc. (34.15M), less than Bonus BioGroup Ltd. (213.29M), less than Starpharma Holdings Limited (199.76M), greater than Institute of Biomedical Research Corp. (4.24M), greater than Celyad Oncology S.A. (9.36M), greater than Evolva Holding S.A. (12.59M), greater than MediPharm Labs Corp. (16.20M), greater than Zenith Capital Corp. (4.83M), greater than Charlotte's Web Holdings, Inc. (61.62M), greater than Cell Source, Inc. (48.48M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 34.15M | $16.38M | |
| 213.29M | $46.72M | |
| 199.76M | $169.02M | |
| 4.24M | $4.25M | |
| 9.36M | $13.23M | |
| 12.59M | $15.50M | |
| 16.20M | $19.00M | |
| 4.83M | $4.83M | |
| 61.62M | $62.57M | |
| 48.48M | $35.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Resverlogix Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Resverlogix Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Resverlogix Corp.'s Enterprise Value?
What is the highest Enterprise Value for Resverlogix Corp. (RVXCF)?
What is the 3-year average Enterprise Value for Resverlogix Corp. (RVXCF)?
What is the 5-year average Enterprise Value for Resverlogix Corp. (RVXCF)?
How does the current Enterprise Value for Resverlogix Corp. (RVXCF) compare to its historical average?